Informations sur le produit
- (1R,3S,5R,7R,8E,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-β-<span class="text-smallcaps">D</span>-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- (8E)-22-[(3-amino-3,6-dideoxy-beta-D-glycero-hexopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- 6,11,28-Trioxatricyclo(22.3.1.05,7)octacowq-8,14,16,18,20-pentaene-25-carboxylic acid, 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-β-<span class="text-smallcaps">D</span>-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosane, lucensomycin deriv.
- Antibiotic 1163 F.I.
- Antibiotic FI 1163
- Antibiotic obtained from cultures of Streptomyces lucensis, or the same substance produced by any other means
- Etruscomicina
- Etruscomycin
- Voir d'autres synonymes
- Fi 1163
- Leucensomycin
- Lucensomycin
- Nsc 143257
- Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo(33.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosane, lucensomycin deriv.
- (1R,3S,5R,7R,8E,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Lucimycin is a polyene antibiotic that has been shown to have strong anti-infective properties against microbial infection. It is active against both Gram-positive and Gram-negative bacteria, including resistant mutants. Lucimycin has been shown to interact with hydroxyl groups on the bacterial cell membrane, which may be due to its ability to form polymers. The polyene structure also allows for binding to the DNA polymerase of the bacterial cell. Lucimycin has been found to be effective in treating choroidal neovascularization, a condition where new blood vessels grow on or near the retina and can lead to blindness. This drug also interacts with sodium citrate and proton pumps in the intestine, which may be responsible for its ability to treat diarrhoea.
Propriétés chimiques
Question d’ordre technique sur : 3D-FL177686 Lucimycin
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages